[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pediatric-burns\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pediatric-burns":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100604121","69--5000-the-effect-of-mandala-painting-on-pain-stress-and-sleep-quality-in-children-hospitalized-in-the-burn-unit-a-randomized-controlled-study-100604121",false,"NCT07145398","69 \u002F 5.000 THE EFFECT OF MANDALA PAINTING ON PAIN, STRESS, AND SLEEP QUALITY IN CHILDREN HOSPITALIZED IN THE BURN UNIT: A RANDOMIZED CONTROLLED STUDY","THE EFFECT OF MANDALA PAINTING ON PAIN, STRESS, AND SLEEP QUALITY IN CHILDREN HOSPITALIZED IN THE BURN UNIT: A RANDOMIZED CONTROLLED STUDY","Inclusion Criteria:\n\n* Both the parent and the child are willing to participate in the study.\n* Child is between 6 and 12 years of age.\n* Burn degree is 1st or 2nd degree.\n* The child does not have an acute psychiatric diagnosis (e.g., severe anxiety disorder, psychotic conditions).\n* The child has basic fine motor skills (e.g., ability to hold a pencil, ability to color).\n* The child does not have any chronic illness.\n* The child has newly initiated burn treatment.\n\nExclusion Criteria:\n\n* Parent or child is not willing to participate in the study.\n* Burn degree is 3rd or 4th degree.\n* The child has any chronic illness.\n* The child has a developmental disorder.\n* The child has visual perception impairments (e.g., color blindness, severe visual loss).","ALL","6 Years","12 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","The mandala coloring method allows patients to focus their attention on a circle and use colors with repetitive movements. This state of focus and relaxation can have positive effects on anxiety and other negative moods. There are a limited number of studies in the literature on the use of mandala coloring in children. Therefore, the study was designed to investigate the effects of mandala coloring on pain, stress, and sleep quality in children hospitalized in the burn unit.",[27,28],"Pediatric Burns","Pediatric Burn",[30,31,32,33,34],"pediatric burn","mandala painting","paın","stress","sleep quality","NOT_YET_RECRUITING","2025-08-27",{"date":38,"type":39},"2025-08-28","ACTUAL",{"date":41,"type":21},"2025-08-25",{"date":43,"type":21},"2026-06-05",{"name":45,"class":46},"Yuzuncu Yil University","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":47},"100602690","phase-1-magnesium-sulfate-in-pediatric-burn-dressing-changes-100602690","NCT07126795","Magnesium Sulfate in Pediatric Burn Dressing Changes","Magnesium Sulfate for Adjuvant Analgesia in Pediatric Burn Dressing Changes: a Pilot Study","Inclusion Criteria:\n\n* \\\u003C 18 years old at time of randomization completion\n* admission to HCMC Burn Unit\n* Projected multi-day sedated dressing change requirement\n* Intention for IV Ketamine as primary analgosedative agent\n\nExclusion Criteria:\n\n* age \\\u003C 3 years (may lower pending FDA discussions)\n* Evidence of hypermagnesemia - pre-study serum Mg2+ level \\> 2.5 mg\u002FdL\n* Evidence of renal dysfunction - serum Cr level \\> 1.5x hospital upper limit normal for age\n* Presence of neuromuscular disease (specifically myasthenia gravis), underlying bradyarrhythmia or heart block\n* Bronchospastic disease (asthma, reactive airway disease) which requires continuous magnesium sulfate infusion\n* Active prescription of a calcium channel blocker (amlodipine, isradipine, nicardipine, nifedipine, clevidipine, diltiazem, verapamil), cardiac glycoside (digoxin), parenteral nutrition or an infusion for hemodynamic support (epinephrine, norepinephrine, dopamine, dobutamine, milrinone, etc)\n* Known allergy or reaction to magnesium sulfate, aluminum, or a component of the formulation\n* Presence of invasive mechanical ventilation\n* Anticipation of skin grafting within 5 days of study eligibility\n* Anyone whom child protective services are consulted\n* Any investigational drug use within 30 days prior to enrollment\n* Pregnant or lactating females\n* Anyone whom in the opinion of the investigator is at higher than anticipated risk of harm or inability to adhere to protocol\n* Patients who choose to opt out of research","3 Years","18 Years",{"count":58,"type":21},10,[60],"PHASE1","Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia\u002Fsedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and\u002For sedative requirements.",[27],[64,65,66,67,68,69],"magnesium sulfate","pediatrics","burn","analgesia","sedation","burn dressing change","2025-08-16",{"date":72,"type":39},"2025-08-22",{"date":74,"type":21},"2026-01-01",{"date":76,"type":21},"2027-01-01",{"name":78,"class":46},"Hennepin Healthcare Research Institute"]